STUB1 and atrial fibrillation: Importantly, in the UK Biobank cohort, AF patients with CHIP mutations had a 1.32-fold higher risk of the composite outcome of HF, IS, and death, primarily driven by a 1.27-fold increased risk of HF and a 1.54-fold higher risk of death [40].